explore -WSS

explore

author：entertainment 2025-09-29 16:34:26 - browse：5

accountable care organizations cost saving — Adobe

WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Trump to be booked at notorious Fulton County Jail at center of DOJ probe

knowledge

entertainment

WSS

What drug price negotiations mean for Medicare Part D

Amazon on where the company's health care bets are headed next

How the drug

The 10 drugs up first for Medicare price negotiation

Stem cell treatment guidelines are released by FDA

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

entertainment

explore

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Kellogg’s is going to war over Mexico’s nutrition label rules

Hollywood unions extend contract negotiations for actors

The (many) problems with a new study criticizing cancer screening

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Cancer drug shortages should be causing more outrage

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

In age of alternative facts, a scholarly course on calling out crap

Abortion policy in the spotlight at Republican debate

Wikipedia

FDA advisory panel to debate high blood pressure devices

Stem cell treatment guidelines are released by FDA

Amazon on where the company's health care bets are headed next

Snackable artificial intelligence, expert AI, and the pharma industry

Humana sues Biden admin over Medicare Advantage audit rule

NIH nominee Bertagnolli will get October confirmation hearing

entertainment

knowledge

entertainment

focus